| Tau PET in autosomal dominant Alzheimer’s disease: relationship with cognition, dementia and other biomarkers BA Gordon, TM Blazey, J Christensen, A Dincer, S Flores, S Keefe, ... Brain 142 (4), 1063-1076, 2019 | 152 | 2019 |
| Mapping connections in humans and non-human primates: aspirations and challenges for diffusion imaging DC Van Essen, S Jbabdi, SN Sotiropoulos, C Chen, K Dikranian, ... Diffusion mri, 337-358, 2014 | 129 | 2014 |
| Parenchymal border macrophages regulate the flow dynamics of the cerebrospinal fluid A Drieu, S Du, SE Storck, J Rustenhoven, Z Papadopoulos, T Dykstra, ... Nature 611 (7936), 585-593, 2022 | 111 | 2022 |
| Soluble TREM2 in CSF and its association with other biomarkers and cognition in autosomal-dominant Alzheimer's disease: a longitudinal observational study E Morenas-Rodríguez, Y Li, B Nuscher, N Franzmeier, C Xiong, ... The Lancet Neurology 21 (4), 329-341, 2022 | 95 | 2022 |
| CSF MTBR-tau243 is a specific biomarker of tau tangle pathology in Alzheimer’s disease K Horie, G Salvadó, NR Barthélemy, S Janelidze, Y Li, Y He, B Saef, ... Nature medicine 29 (8), 1954-1963, 2023 | 56 | 2023 |
| Novelty, salience, and surprise timing are signaled by neurons in the basal forebrain K Zhang, CD Chen, IE Monosov Current Biology 29 (1), 134-142. e3, 2019 | 55 | 2019 |
| Quantification of white matter cellularity and damage in preclinical and early symptomatic Alzheimer's disease Q Wang, Y Wang, J Liu, CL Sutphen, C Cruchaga, T Blazey, BA Gordon, ... NeuroImage: Clinical 22, 101767, 2019 | 52 | 2019 |
| Cerebrospinal fluid proteomics define the natural history of autosomal dominant Alzheimer’s disease ECB Johnson, S Bian, RU Haque, EK Carter, CM Watson, BA Gordon, ... Nature medicine 29 (8), 1979-1988, 2023 | 37 | 2023 |
| Predicting brain age from functional connectivity in symptomatic and preclinical Alzheimer disease PR Millar, PH Luckett, BA Gordon, TLS Benzinger, SE Schindler, ... Neuroimage 256, 119228, 2022 | 34 | 2022 |
| High soluble amyloid-β 42 predicts normal cognition in amyloid-positive individuals with Alzheimer’s disease-causing mutations A Sturchio, AK Dwivedi, T Malm, MJA Wood, R Cilia, JS Sharma, EJ Hill, ... Journal of Alzheimer's Disease 90 (1), 333-348, 2022 | 34 | 2022 |
| Multiple mechanisms for processing reward uncertainty in the primate basal forebrain NM Ledbetter, CD Chen, IE Monosov Journal of Neuroscience 36 (30), 7852-7864, 2016 | 33 | 2016 |
| Highly accurate blood test for Alzheimer’s disease is similar or superior to clinical cerebrospinal fluid tests NR Barthélemy, G Salvadó, SE Schindler, Y He, S Janelidze, LE Collij, ... Nature medicine 30 (4), 1085-1095, 2024 | 27 | 2024 |
| Multimodal brain age estimates relate to Alzheimer disease biomarkers and cognition in early stages: a cross-sectional observational study PR Millar, BA Gordon, PH Luckett, TLS Benzinger, C Cruchaga, ... Elife 12, e81869, 2023 | 25 | 2023 |
| Association of BDNF Val66Met with tau hyperphosphorylation and cognition in dominantly inherited Alzheimer disease YY Lim, P Maruff, NR Barthélemy, A Goate, J Hassenstab, C Sato, ... JAMA neurology 79 (3), 261-270, 2022 | 21 | 2022 |
| Temporal correlation of CSF and neuroimaging in the amyloid-tau-neurodegeneration model of Alzheimer disease AH Boerwinkle, JK Wisch, CD Chen, BA Gordon, OH Butt, SE Schindler, ... Neurology 97 (1), e76-e87, 2021 | 21 | 2021 |
| Etiology of white matter hyperintensities in autosomal dominant and sporadic Alzheimer disease Z Shirzadi, SA Schultz, WYW Yau, N Joseph-Mathurin, CD Fitzpatrick, ... JAMA neurology 80 (12), 1353-1363, 2023 | 17 | 2023 |
| Metabolomic and lipidomic signatures in autosomal dominant and late‐onset Alzheimer's disease brains BC Novotny, MV Fernandez, C Wang, JP Budde, K Bergmann, ... Alzheimer's & Dementia 19 (5), 1785-1799, 2023 | 16 | 2023 |
| Comparison of amyloid burden in individuals with Down syndrome versus autosomal dominant Alzheimer's disease: a cross-sectional study AH Boerwinkle, BA Gordon, J Wisch, S Flores, RL Henson, OH Butt, ... The Lancet Neurology 22 (1), 55-65, 2023 | 16 | 2023 |
| APOE ε4 genotype, amyloid-β, and sex interact to predict tau in regions of high APOE mRNA expression A Dincer, CD Chen, NS McKay, LN Koenig, A McCullough, S Flores, ... Science translational medicine 14 (671), eabl7646, 2022 | 16 | 2022 |
| Amyloid‐related imaging abnormalities in the DIAN‐TU‐001 Trial of Gantenerumab and Solanezumab: lessons from a trial in dominantly inherited Alzheimer disease N Joseph‐Mathurin, JJ Llibre‐Guerra, Y Li, AA McCullough, C Hofmann, ... Annals of neurology 92 (5), 729-744, 2022 | 16 | 2022 |
